Evidence map›Paper›PMID 36191024›Full record

ArticlePloS one2022

Subjective and psychophysical olfactory and gustatory dysfunction among COVID-19 outpatients; short- and long-term results.

Mads Mose Jensen, Kasper Daugaard Larsen, Anne-Sophie Homøe, Anders Lykkemark Simonsen, Elisabeth Arndal, Anders Koch, Grethe Badsberg Samuelsen, Xiaohui Chen Nielsen, Tobias Todsen, Preben Homøe

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Subjective versus Psychophysical Measures of Chemosensory Alterations following COVID-19.ORL; journal for oto-rhino-laryngology and its related specialties · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Mads Mose JensenDepartment of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Koege, Denmark.ORCID 0000-0003-4193-6457
Kasper Daugaard LarsenDepartment of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Koege, Denmark.
Anne-Sophie HomøeDepartment of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Koege, Denmark.
Anders Lykkemark SimonsenDepartment of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Elisabeth ArndalDepartment of Otolaryngology-Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-7858-5684
Anders KochDepartment of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Grethe Badsberg SamuelsenDepartment of Otorhinolaryngology, Nordsjaellands Hospital, Hilleroed, Denmark.
Xiaohui Chen NielsenDepartment of Clinical Microbiology, Zealand University Hospital, Koege, Denmark.
Tobias TodsenDepartment of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Koege, Denmark.
Preben HomøeDepartment of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Koege, Denmark.
Rigshospitalet · DKZealand University Hospital · DKUniversity of Copenhagen · DKNordsjællands Hospital · DKStatens Serum Institut · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOlfactory and gustatory dysfunctions are early symptoms of SARS-CoV-2 infection. Between 20-80% of infected individuals report subjective altered sense of smell and/or taste during infection. Up to 2/3 of previously infected experience persistent olfactory and/or gustatory dysfunction after 6 months. The aim of this study was to examine subjective and psychophysical olfactory and gustatory function in non-hospitalized individuals with acute COVID-19 up to 6 months after infection.

methodsIndividuals aged 18-80-years with a positive SARS-CoV-2 PCR test no older than 10 days, were eligible. Only individuals able to visit the outpatient examination facilities were included. Gustatory function was tested with the Burgharts Taste Strips and olfactory function was examined with the Brief Smell Identifications test (Danish version). Subjective symptoms were examined through an online questionnaire at inclusion, day 30, 90 and 180 after inclusion.

resultsFifty-eight SARS-CoV-2 positive and 56 negative controls were included. 58.6% (34/58) of SARS-CoV-2 positive individuals vs. 8.9% (5/56) of negative controls reported subjective olfactory dysfunction at inclusion. For gustatory dysfunction, 46.5% (27/58) of positive individuals reported impairment compared to 8.9% (5/56) of negative controls. In psychophysical tests, 75.9% (46/58) had olfactory dysfunction and 43.1% (25/58) had gustatory dysfunction among the SARS-CoV-2 positive individuals at inclusion. Compared to negative controls, SARS-CoV-2 infected had significantly reduced olfaction and gustation. Previously infected individuals continued to report lower subjective sense of smell 30 days after inclusion, whereafter the difference between the groups diminished. However, after 180 days, 20.7% (12/58) positive individuals still reported reduced sense of smell and taste.

conclusionOlfactory and gustatory dysfunctions are prevalent symptoms of SARS-CoV-2 infection, but there is inconsistency between subjective reporting and psychophysical test assessment of especially olfaction. Most individuals regain normal function after 30 days, but approximately 20% report persistent olfactory and gustatory dysfunction 6 months after infection.

Indexed as

COVID-19Olfaction DisordersHumansOutpatientsSARS-CoV-2SmellTaste Disorders

Identifiers

PMID36191024
PMCPMC9529127
OpenAlexW4300687923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.